TransMedics Group Total Assets Growth & History (TMDX)
TransMedics Group's total assets was $1.07B for fiscal 2025.
View full TransMedics Group company overviewTransMedics Group annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.07B | $264.3M | +32.87% |
| 2024 | 2024-12-31 | $804.1M | $98.0M | +13.88% |
| 2023 | 2023-12-31 | $706.0M | $428.9M | +154.76% |
| 2022 | 2022-12-31 | $277.1M | $142.3M | +105.46% |
| 2021 | 2021-12-31 | $134.9M | −$17.1M | −11.27% |
| 2020 | 2020-12-31 | $152.0M | $46.7M | +44.38% |
| 2019 | 2019-12-28 | $105.3M | $63.1M | +149.78% |
| 2018 | 2018-12-29 | $42.2M | — | — |
TransMedics Group quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.46B | $573.9M | +64.44% |
| Q1 2026 | 2026-03-31 | $1.43B | $597.3M | +71.32% |
| Q4 2025 | 2025-12-31 | $1.07B | $264.3M | +32.87% |
| Q3 2025 | 2025-09-30 | $946.0M | $160.5M | +20.43% |
| Q2 2025 | 2025-06-30 | $890.5M | $131.9M | +17.39% |
| Q1 2025 | 2025-03-31 | $837.5M | $113.7M | +15.71% |
| Q4 2024 | 2024-12-31 | $804.1M | $98.0M | +13.88% |
| Q3 2024 | 2024-09-30 | $785.6M | $96.3M | +13.98% |
| Q2 2024 | 2024-06-30 | $758.6M | $68.2M | +9.88% |
| Q1 2024 | 2024-03-31 | $723.8M | $436.7M | +152.13% |
| Q4 2023 | 2023-12-31 | $706.0M | $428.9M | +154.76% |
| Q3 2023 | 2023-09-30 | $689.2M | $414.4M | +150.74% |
| Q2 2023 | 2023-06-30 | $690.4M | $573.1M | +488.62% |
| Q1 2023 | 2023-03-31 | $287.1M | $163.1M | +131.51% |
| Q4 2022 | 2022-12-31 | $277.1M | $142.3M | +105.46% |
| Q3 2022 | 2022-09-30 | $274.9M | $143.7M | +109.59% |
| Q2 2022 | 2022-06-30 | $117.3M | −$23.2M | −16.53% |
| Q1 2022 | 2022-03-31 | $124.0M | −$21.8M | −14.94% |
| Q4 2021 | 2021-12-31 | $134.9M | −$17.1M | −11.27% |
| Q3 2021 | 2021-09-30 | $131.1M | −$28.2M | −17.68% |
| Q2 2021 | 2021-06-30 | $140.5M | −$22.6M | −13.87% |
| Q1 2021 | 2021-03-31 | $145.8M | $48.9M | +50.41% |
| Q4 2020 | 2020-12-31 | $152.0M | $46.7M | +44.38% |
| Q3 2020 | 2020-09-30 | $159.3M | $46.7M | +41.47% |
| Q2 2020 | 2020-06-30 | $163.1M | $42.1M | +34.81% |
| Q1 2020 | 2020-03-31 | $96.9M | $58.2M | +150.07% |
| Q4 2019 | 2019-12-28 | $105.3M | $63.1M | +149.78% |
| Q3 2019 | 2019-09-28 | $112.6M | — | — |
| Q2 2019 | 2019-06-29 | $121.0M | — | — |
| Q1 2019 | 2019-03-30 | $38.8M | — | — |
| Q4 2018 | 2018-12-29 | $42.2M | — | — |
TransMedics Group total assets trends
Over the last five fiscal years, TransMedics Group's total assets increased from $152.0M to $1.07B, a change of $916.3M. The latest reported quarter, Q2 2026, shows $1.46B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TransMedics Group source filings ↗